BMPR2 and pulmonary arterial hypertension: The most commonly studied gene mutation in relation to PAH pathogenesis is with BMPRII. Animal models demonstrate that reduced BMPRII activity in pulmonary vascular endothelial cells increases the incidence of apoptosis, leading to vascular remodelling and ultimately PAH [23,24].